11 полученные результаты
The invention relates to the use of 1,2-benzopyrone derivatives for producing medicaments for the therapeutic treatment of susceptible malignant tumors in humans.
The concepts currently available for oncological therapy include therapy with substances or radiation in order to thus achieve an
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to novel 5-iodo-6-amino-1,2-benzopyrones and their metabolites, very potent, selective and safe cytostatic and antiviral agents, and to a method of treatment of tumorigenic and viral diseases using
TECHNICAL FIELD
The present invention relates to benzopyrone compounds, the salts, or the prodrugs thereof, pharmaceutical compositions comprising the compounds, and use of the compounds in preventing and/or treating the estrogen receptor related diseases.
BACKGROUND
Estrogens are a group of
Cross Reference to Related Applications
This application is related to copending applications Ser. No. 07/780,809 filed Oct. 22, 1991 and Ser. No. 07/893,429 filed Jun. 4, 1992, the disclosures of which are incorporated herein by reference.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to novel 5-iodo-6-amino-1,2-benzopyrones and their metabolites, very potent, selective and safe cytostatic and antiviral agents, and to a method of treatment of tumorigenic and viral diseases using
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to novel 5-iodo-6-amino-1,2-benzopyrones and their metabolites, very potent, selective and safe cytostatic and antiviral agents, and to a method of treatment of tumorigenic and viral diseases using
FIELD OF THE INVENTION
The present invention relates generally to the field of retroviral therapeutic and inactivating agents and their use in treating retroviral infections and cancers. More specifically it relates to those therapeutic and inactivating C-nitroso compounds which destabilize zinc
FIELD OF THE INVENTION
The present invention relates generally to the field of retroviral therapeutic and inactivating agents and their use in treating retroviral infections and cancers. More specifically it relates to those therapeutic and inactivating C-nitroso compounds which destabilize zinc
FIELD OF THE INVENTION
The present invention relates generally to the field of retroviral therapeutic and inactivating agents and their use in treating retroviral infections and cancers. More specifically it relates to those therapeutic and inactivating C-nitroso compounds which destabilize zinc
FIELD OF THE INVENTION
The present invention relates generally to the field of retroviral therapeutic and inactivating agents and their use in treating retroviral infections and cancers. More specifically it relates to those therapeutic and inactivating C-nitroso compounds which destabilize zinc
FIELD OF THE INVENTION
The present invention relates generally to the field of retroviral therapeutic and inactivating agents and their use in treating retroviral infections and cancers. More specifically it relates to those therapeutic and inactivating C-nitroso compounds which destabilize zinc